Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society

The Revised International Staging System (R-ISS) was developed for a more accurate risk stratification of patients with symptomatic multiple myeloma (MM). However, original and subsequent validation studies of the R-ISS included relatively younger patients, many of whom were treated without bortezom...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Yoshiaki, Sunami, Kazutaka, Yamashita, Takeshi, Ueda, Mikio, Takamatsu, Hiroyuki, Narita, Kentaro, Kobayashi, Hiroki, Kitadate, Akihiro, Takeuchi, Masami, Matsue, Kosei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355174/
https://www.ncbi.nlm.nih.gov/pubmed/30728910
http://dx.doi.org/10.18632/oncotarget.26562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355174/
https://www.ncbi.nlm.nih.gov/pubmed/30728910
http://dx.doi.org/10.18632/oncotarget.26562

Ejemplares similares